12:00 AM
 | 
May 14, 2007
 |  BioCentury  |  Regulation

Cancer immunotherapy milestones

Cancer immunotherapy milestones

Company Product Indication Status/milestone
Accentia BiovaxID Follicular non-Hodgkin's lymphoma (NHL)...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >